Malta - anglès - Medicines Authority

bayer limited 1st floor the grange offices the grange brewery road stillorgan co. dublin, a94 h2k7 , ireland - calcium carbonate, magnesium carbonate, heavy - chewable tablet - calcium carbonate 680 mg magnesium carbonate, heavy 80 mg - drugs for acid related disorders

Malta - anglès - Medicines Authority

bayer limited 1st floor the grange offices the grange brewery road stillorgan co. dublin, a94 h2k7 , ireland - calcium carbonate, magnesium carbonate, heavy - chewable tablet - calcium carbonate 680 mg magnesium carbonate, heavy 80 mg - drugs for acid related disorders

Malta - anglès - Medicines Authority

bayer limited 1st floor the grange offices the grange brewery road stillorgan co. dublin, a94 h2k7 , ireland - calcium carbonate, magnesium carbonate, heavy - chewable tablet - calcium carbonate 680 mg magnesium carbonate, heavy 80 mg - drugs for acid related disorders

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

bayer limited - calcium carbonate; magnesium carbonate - chewable tablet - 680 mg/80 milligram(s) - magnesium carbonate; calcium carbonate; antacids, other combinations

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

bayer limited - calcium carbonate; magnesium carbonate - chewable tablet - 680 mg/80 milligram(s) - magnesium carbonate; calcium carbonate; antacids, other combinations

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

bayer limited - magnesium carbonate; calcium carbonate - chewable tablet - 680/80 milligram(s) - combinations and complexes of aluminium, calcium and magnesium compounds; ordinary salt combinations

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

the boots company plc - magnesium trisilicate light; magnesium trisilicate heavy; magnesium carbonate light; sodium bicarbonate - oral suspension - 166.6mg/1ml ; 33.34mg/1ml ; 50mg/1ml ; 50mg/1ml

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - sodium chloride - intravenous inf solution - 0.9 %w/v - sodium chloride

Estats Units - anglès - NLM (National Library of Medicine)

x-gen pharmaceuticals, inc. - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - pravastatin sodium, quantity: 80 mg - tablet, film coated - excipient ingredients: lactose monohydrate; crospovidone; sodium bicarbonate; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; macrogol 8000; purified talc; iron oxide yellow - 1. as an adjunct to diet for the treatment of hypercholesterolaemia. prior to initiating therapy with pravastatin generichealth, secondary causes of hypercholesterolaemia (eg, poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. 2. pravastatin generichealth is indicated in patients with previous myocardial infarction including those who have normal (4.0-5.5 mmol/l) serum cholesterol levels. 3. pravastatin generichealth is indicated in patients with unstable angina pectoris (see clinical trials). 4. pravastatin generichealth is indicated as an adjunct to diet and lifestyle modification for the treatment of heterozygous familial hypercholesterolaemia in children and adolescent patients aged 8 years and older (see clinical trials).